mechanism of action of glp-1 receptor agonists Current Insights, Advantages and Challenges Small Molecule Glucagon-like Peptide 1 Agonists: A Scoping Review Frontiers | GLP−1 receptor agonists

Obstructive sleep apnea is directly linked to daytime somnolence, cognitive impairment, and decreased quality of life, and has been associated with broader health conditions, including high blood pressure, heart attacks, heart failure, and diabetes

doi: 10.3389/fnins.2022.970925

GLP-1RAs not only have the potential to treat the above-mentioned diseases but also ameliorate the co-morbidities simultaneously, which is important for patients with autoimmune/autoinflammatory diseases combined with metabolic diseases

Claxton A, Baker LD, Wilkinson CW, Trittschuh EH, Chapman D, Watson GS, et al

Further analyses revealed that cotadutide 300 g improved lipid profiles, liver enzyme levels (AST and ALT), and markers of liver fibrosis, including propeptide of type III collagen, and fibrosis-4 index, compared to placebo

Results Study selection A total of 645 studies were identified through database searches in PubMed, Ovid and The Cochrane Library